Active surveillance versus treatment in low-risk DCIS: Women's preferences in the LORD-trial. Schmitz RSJM, Engelhardt EG, Gerritsma MA, Sondermeijer CMT, et al. Eur J Cancer 2023;192:113276.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Schmitz RSJM, Engelhardt EG, Gerritsma MA, Sondermeijer CMT, et al. Active surveillance versus treatment in low-risk DCIS: Women's preferences in the LORD-trial. Eur J Cancer 2023;192:113276.
PMID: 37657228